STAGE IB BREAST CANCER AJCC V7
Clinical trials for STAGE IB BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Video chats and smart pill bottles boost breast cancer treatment adherence
Disease control CompletedThis study looked at whether using telehealth (video chats with doctors) and smart pill bottles can help breast cancer patients take their hormone therapy pills more regularly. About 305 patients with early-stage hormone-sensitive breast cancer took part. The goal was to see if t…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study tested a treatment plan for people with early-stage HER2-positive breast cancer. After surgery, they received two chemotherapy drugs (cyclophosphamide and paclitaxel) plus a targeted therapy (trastuzumab). The goal was to see if this combination is safe and helps stop …
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New drug cocktail shrinks tough breast tumors before surgery
Disease control CompletedThis study tested a combination of three drugs (panitumumab, carboplatin, and paclitaxel) given before surgery to women with triple-negative breast cancer whose tumors did not respond to standard chemotherapy. The goal was to shrink tumors and reduce the amount of breast tissue t…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New drug combo shows promise for tough breast cancer
Disease control CompletedThis study tested a treatment combining enzalutamide (blocks male hormones) and paclitaxel (chemotherapy) given before surgery to women with a specific type of triple-negative breast cancer that has androgen receptors. The goal was to shrink tumors and reduce the amount of breast…
Matched conditions: STAGE IB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:55 UTC